Taipei Medical University

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Huang SS, Ling TY, Tseng WF, Huang YH, Tang FM, Leal SM and Huang JS
------>authors3_c=None
------>paper_class1=1
------>Impact_Factor=6.820
------>paper_class3=2
------>paper_class2=1
------>vol=17
------>confirm_bywho=None
------>insert_bywho=rita1204
------>Jurnal_Rank=3.1
------>authors4_c=None
------>comm_author=
------>patent_EDate=None
------>authors5_c=None
------>publish_day=1
------>paper_class2Letter=None
------>page2=2081
------>medlineContent=
------>unit=E0103
------>insert_date=20031006
------>iam=4
------>update_date=
------>author=???
------>change_event=6
------>ISSN=
------>authors_c=None
------>score=486
------>journal_name=FASEB J
------>paper_name=Cellular growth inhibition by IGFBP-3 and TGF-beta1 required LRP-1.
------>confirm_date=None
------>tch_id=090143
------>pmid=14597676
------>page1=2068
------>fullAbstract=The type V TGF-beta receptor (TbetaR-V)/IGFBP-3 receptor mediates the IGF-independent growth inhibition induced by IGFBP-3. It also mediates the growth inhibitory response to TGF-beta1 in concert with other TGF-beta receptor types, and its loss may contribute to the malignant phenotype of human carcinoma cells. Here we demonstrate that TbetaR-V is identical to LRP-1/alpha2M receptor as shown by MALDI-TOF analysis of tryptic peptides of TbetaR-V purified from bovine liver. In addition, 125I-IGFBP-3 affinity-labeled TbetaR-V in Mv1Lu cells is immunoprecipitated by antibodies to LRP-1 and TbetaR-V. RAP, an LRP-1 antagonist, inhibits binding of 125I-TGF-beta1 and 125I-IGFBP-3 to TbetaR-V and diminishes IGFBP-3-induced growth inhibition in Mv1Lu cells. Absent or low levels of LRP-1, as with TbetaR-V, have been linked to the malignant phenotype of carcinoma cells. Mutagenized Mv1Lu cells selected for reduced expression of LRP-1 have an attenuated growth inhibitory response to TGF-beta1 and IGFBP-3. LRP-1-deficient mouse embryonic fibroblasts lack a growth inhibitory response to TGF-beta1 and IGFBP-3. On the other hand, stable transfection of H1299 human lung carcinoma cells with LRP-1 cDNA restores the growth inhibitory response. These results suggest that the LRP-1/TbetaR-V/IGFBP-3 receptor is required for the growth inhibitory response to IGFBP-3 and TGF-beta1.
------>tmu_sno=None
------>sno=7577
------>authors2=
------>authors3=
------>authors4=
------>authors5=
------>authors6=
------>authors6_c=None
------>authors=Huang SS, Ling TY, Tseng WF, Huang YH, Tang FM, Leal SM and Huang JS
------>delete_flag=0
------>SCI_JNo=None
------>authors2_c=None
------>publish_area=0
------>updateTitle=Cellular growth inhibition by IGFBP-3 and TGF-beta1 requires LRP-1.
------>language=2
------>check_flag=
------>submit_date=
------>country=None
------>no=14
------>patent_SDate=None
------>update_bywho=
------>publish_year=2003
------>submit_flag=
------>publish_month=11
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z